Rallybio Sets One-for-Two Reverse Stock Split Ahead of Avenzo Merger
Rallybio Corporation announced a one-for-two reverse stock split effective November 20, 2026, as a procedural step to facilitate its merger with Avenzo…
Rallybio Corporation announced a one-for-two reverse stock split effective November 20, 2026, as a procedural step to facilitate its merger with Avenzo…
Enovix Corporation will distribute warrants (ENVXW) to shareholders on November 18, 2026, based on a one-for-four ratio for shares held by the…
Arrive AI (ARAI) is set to undergo a 1-for-48 reverse stock split on November 12, 2026, accompanied by a CUSIP number change…
Netfonds AG confirms its decision to delist from the Munich Stock Exchange, correcting a prior announcement from November 9, 2026.
GeoVax Labs will implement a 1-for-24 reverse stock split effective November 11, 2026, with the company's CUSIP number changing to 373678804.
Silexion Therapeutics Corp. will execute a 1-for-24 reverse stock split effective November 11, 2026, alongside a par value change to $3.24 and…
General Motors is shifting its primary listing to the Nasdaq exchange on November 17, 2026, with the company maintaining its existing GM…
Cell Impact begins the exercise period for TO5 warrants, setting the price at 0.05 SEK per share, with the window open until…
OFA Group (OFAL) announces a 1-for-10 reverse stock split effective November 10, 2026, alongside a CUSIP number change to G6713S122 to maintain…
Neo-Concept International Group will implement a 1-for-8 reverse stock split on November 10, 2026, accompanied by a par value increase and a…
SMX (Security Matters) will undergo a 1-for-2.8 reverse stock split on November 9, 2026, accompanied by a par value change and a…
Boule Diagnostics proposes a massive 3-for-1 rights issue and a directed share issuance to address debt obligations and bolster liquidity, with an…